Oculis Holding AG: 5%+ holders

As of November 6, 2026, one holder's latest Schedule 13D or 13G filing report owning 5% or more of Oculis Holding AG. The largest reported stake is LSP 7 Cooperatieve U.A.'s, at 11.8%. 3 filings are on record since November 14, 2025 (Schedule 13G/A, April 29, 2026).

Nan Fung Group Holdings Limited also filed stake reports on 2 other companies ↓

Sell to companies like Oculis Holding AG? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Your website Find my buyers

Opens in a new tab. No signup.

Key facts

• Filing 2026-04-29 · Reporting person: LSP 7 Cooperatieve U.A. · Sole voting: 0 · Shared voting: 6,950,294 · Sole dispositive: 0 · Shared dispositive: 6,950,294 · SCHEDULE 13G/A, 2026-04-29
• Filing 2026-03-27 · Reporting person: Bvcf Iv, L.P. · Sole voting: 0 · Shared voting: 2,436,902 · Sole dispositive: 0 · Shared dispositive: 2,436,902 · SCHEDULE 13G/A, 2026-03-27
• Filing 2025-11-14 · Reporting person: Nan Fung Group Holdings Limited · Sole voting: 0 · Shared voting: 2,815,476 · Sole dispositive: 0 · Shared dispositive: 2,815,476 · SCHEDULE 13G/A, 2025-11-14

Oculis Holding AG has 3 Schedule 13D or 13G filings on record since 2025-11-14. 1 holder's latest filing reports 5% or more of ordinary shares, par value chf 0.01 per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

Swipe the table sideways to see every column.

Holding shares or following this stake? See who's behind Oculis Holding AG and the warning signs.

See Oculis Holding AG's free Snapshot Watch Oculis Holding AG: email me the next time it files something

Free to see. No signup.

Keep reading

More on Oculis Holding AG and the records around it.

Companies that share a holder

• Nan Fung Group Holdings Limited also filed stake reports on 2 other companies: Bolt Biotherapeutics, Inc. (Feb 2026), Evommune, Inc. (Feb 2026)
• LSP 7 Cooperatieve U.A. also filed stake reports on 3 other companies: Electra Therapeutics, Inc. (Sep 2026), Evommune, Inc. (Feb 2026), AgomAb Therapeutics NV (Feb 2026)

Want the whole picture on Oculis Holding AG?

Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News

A Full Report on Oculis Holding AG: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Oculis Holding AG covers

1. The Short Answer

2. Which Company This Is

3. What They Do, And How The Money Works

4. Who Runs It, And How To Reach Them

5. The Money: Funding, Valuation, Runway

6. Who Pays Them, And Who They Are Up Against

7. Warning Bells

8. Sources

   3 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

Order Full ReportSee a sample report

A real finished report, first screen. Opens in a new tab.

Voting and dispositive power, as filed

Swipe the table sideways to see every column.

The latest filing identifies Oculis Holding AG by CUSIP H5870P102 and gives its principal executive office as Bahnhofstrasse 20, Zug (SCHEDULE 13G/A, 2026-04-29).

What the percentages are based on

The information required by this item with respect to each Reporting Person is set forth in Row 11 of the cover page to this Schedule 13G. The ownership percentages are based on 57,169,475 outstanding Ordinary Shares as reported in Exhibit 99.1 to the Issuer's Form 6-K furnished to the Securities and Exchange Commission on October 31, 2025.Nan Fung Group Holdings Limited, SCHEDULE 13G/A, 2025-11-14

Timeline

Swipe the table sideways to see every column.

Questions about who owns Oculis Holding AG

Who owns Oculis Holding AG?

On this page, one holder's latest ownership filing reports 5% or more of Oculis Holding AG: LSP 7 Cooperatieve U.A. (11.8%, Schedule 13G/A, filed 2026-04-29).

When did LSP 7 Cooperatieve U.A. buy into Oculis Holding AG?

The filings give report dates, not purchase dates. The earliest filing from LSP 7 Cooperatieve U.A. on this page is the Schedule 13G/A, filed 2026-04-29, reporting 11.8%. That earliest filing is itself an amendment, which updates an earlier report.

Is this an audit or a full list?

Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 3 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.

Tools for this story

Each opens in a new tab, filled in for Oculis Holding AG. With no account yet, you sign up free and land on the result.

• Get an alert when Oculis Holding AG is mentioned again
• Find former Oculis Holding AG employees to interview
• Verify a claim or statistic

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

All recent stakesThat week's stakes